An error occurred retrieving publication content to display, please try again.
Home >> Journals >> Health Technology Assessment >> Page Not FoundPlease choose a page from the navigation or try a website search above to find the information you need.
Study suggests that sibling donor allogeneic stem cell transplantation may be more effective than chemotherapy in acute myeloid leukaemia in adults and children in first complete remission and acute lymphoblastic leukaemia in adults in first complete remission, and that autologous stem cell transplantation offers no benefit over chemotherapy
{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}
K Ashfaq, I Yahaya, C Hyde, L Andronis, P Barton, S Bayliss & Y-F Chen.
K Ashfaq 1, I Yahaya 1, C Hyde 1, L Andronis 2, P Barton 2, S Bayliss 1, Y-F Chen 1,*
1 West Midlands Health Technology Assessment Collaboration, Public Health, Epidemiology and Biostatistics Unit, School of Health and Population Sciences, University of Birmingham, Edgbaston, Birmingham, UK
2 Health Economics Unit, School of Health and Population Sciences, University of Birmingham, Edgbaston, Birmingham, UK
* Corresponding author Email: y.chen.3@bham.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
[Image - Crossmark status check]The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
No responses have been published.
An error has occurred in processing the XML document
© NIHR 2024